Fresenius Medical Care AG (NYSE:FMS)’s share price gapped down before the market opened on Monday . The stock had previously closed at $42.98, but opened at $43.60. Fresenius Medical Care AG shares last traded at $44.71, with a volume of 114,800 shares trading hands.

Several equities analysts have weighed in on the company. Robert W. Baird restated a “hold” rating on shares of Fresenius Medical Care AG in a report on Monday, May 16th. DZ Bank AG restated a “sell” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 10th. Royal Bank Of Canada restated a “hold” rating on shares of Fresenius Medical Care AG in a report on Tuesday, May 24th. Berenberg Bank reiterated a “buy” rating on shares of Fresenius Medical Care AG in a research note on Tuesday, August 9th. Finally, Jefferies Group upgraded Fresenius Medical Care AG from an “underperform” rating to a “hold” rating in a research note on Friday, July 8th. One analyst has rated the stock with a sell rating, six have given a hold rating and six have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $42.50.

The firm has a 50 day moving average price of $45.35 and a 200-day moving average price of $43.58. The stock has a market cap of $27.34 billion and a price-to-earnings ratio of 24.78.

Fresenius Medical Care AG (NYSE:FMS) last announced its earnings results on Tuesday, August 2nd. The company reported $0.96 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.92 by $0.04. The company earned $4.42 billion during the quarter, compared to analyst estimates of $4.54 billion. On average, analysts anticipate that Fresenius Medical Care AG will post $2.01 EPS for the current year.

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.